Femasys (FEMY) Operating Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
Femasys (FEMY) Operating Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -497.00 |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | 314.00 |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 124.00 |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | 670.00 |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | 546.00 |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | 264.00 |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | -919.00 |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 595.00 |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | 146.00 |
| 10 | Femasys | 9.38 Mn | 7.94 Mn | 189,391.00 | -58,557.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58,557.00 |
| Jun 30, 2025 | 108,260.00 |
| Mar 31, 2025 | -32,304.00 |
| Dec 31, 2024 | 127,586.00 |
| Sep 30, 2024 | 74,778.00 |
| Jun 30, 2024 | -110,767.00 |
| Mar 31, 2024 | -24,243.00 |
| Dec 31, 2023 | -80,702.00 |
| Sep 30, 2023 | -79,030.00 |
| Jun 30, 2023 | -3,847.00 |
| Mar 31, 2023 | -13,772.00 |
| Dec 31, 2022 | -35,382.00 |
| Sep 30, 2022 | -4,471.00 |
| Jun 30, 2022 | -29,441.00 |
| Mar 31, 2022 | -34,304.00 |
| Dec 31, 2021 | -33,464.00 |
| Sep 30, 2021 | -33,554.00 |
| Jun 30, 2021 | 22,655.00 |